Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06098443
Other study ID # P.T.REC/012/004482
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 28, 2023
Est. completion date April 22, 2024

Study information

Verified date December 2023
Source Cairo University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Hemodialysis patients have a high prevalence of pain, mainly musculoskeletal and intra dialytic pain. A high prevalence of pain was also observed in the upper and lower limbs and the trunk. In addition, severe functional interference of pain in the ability to walk was associated with pain in the upper Limb. These results indicate that pain in hemodialysis patients is limiting and disabling (Dos Santos et al., 2021). Acupressure increases relaxation, relieves pain, and reduces anxiety and depression, especially in the elderly. It is relatively inexpensive, safe, non-invasive, and easy to use and is performed by hands, elbows. by applying pressure to specific areas of the body so muscle spasms are relieved, blood circulation and vital energy are improved (Bastani et al.,2022). Strong non-painful TENS within or close to the site of pain produces clinically important reductions in the intensity of pain during or immediately after treatment. With no reports of serious adverse events. TENS as an adjunct to core treatment or immediate short-term relief of pain, irrespective of diagnosis. Patients should be advised to tailor TENS Treatment according to their individual needs (Johnson et al., 2022).


Description:

Sixty patients will be randomly assigned into two equal groups (n=30): 1. Group A (30 patients) will receive Acupressure three times per week for eight weeks. 2. Group B (30 patients) will receive TENS three times per week for eight weeks.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date April 22, 2024
Est. primary completion date January 30, 2024
Accepts healthy volunteers No
Gender Male
Age group 50 Years to 60 Years
Eligibility Inclusion Criteria: - • Sixty patients with renal failure stage 5 undergoing hemodialysis sessions at least six months ago up to 2 years. - Participants with lower limb pain and brief pain inventory (BPI) pain score between 7 and 10 points. - Body mass index ranges from 25 to 29.9. - Their ages range from 50-60 years old. - All patients will be under full medical control. - Patients will be free from lower limb dialysis grafting. - Hemoglobin level more than 10 mg\dl. Exclusion Criteria: - Skin disease such as dermatitis, stitches and wound. - Active infection, autoimmune diseases and malignancy. - Severe cardiac diseases. - Severe chest diseases. - Patients with cardiac pacemaker. - Epilepsy. - Using another integrative treatment method during the study. - Uncontrolled diabetes. - Deep vein thrombosis. - Lumber disc prolapses affect lower limb.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Acupressure
Acupressure is effective on anxiety and depression management. acupressure therapy at K1, ST36, and SP6 acupoints significantly reduced anxiety & depression in patients with ESRD.
Device:
Transcutaneous electrical nerve stimulation
TENS lead to meaningful reduction of pain in patients suffering from difficult to treat phantom limb pain. This treatment has a high success rate and is associated with high satisfaction rates and no reported adverse events. The suggested duration of treatment is at least 30 minutes and may be extended up to 45 minutes. TENS delivers pulsed electric currents across the intact surface of the skin to stimulate peripheral nerves and the spinal cord, resulting in segmental and extra segmental analgesia. TENS delivers pulsed electric currents across the intact surface of the skin to stimulate peripheral nerves and the spinal cord, resulting in segmental and extrasegmental analgesia. (Vathakul et al., 2022).

Locations

Country Name City State
Egypt Cairo University Cairo

Sponsors (1)

Lead Sponsor Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Pain pressure algometry: Pain pressure algometry: Device to measure the intensity of painful stimuli objectively Pain pressure algometry:will be measured at baseline, and it will be measured again after eight weeks
Primary The Brief Pain Inventory (BPI): The Brief Pain Inventory (BPI): Is a multidimensional pain assessment tool used to evaluate pain severity and pain interference. The BPI has been translated and validity estimated across multiple languages and patient populations for clinical and research settings. The Brief Pain Inventory (BPI): will be measured at baseline, and it will be measured again after eight weeks
Primary Short form -36 questionnaire (KDQoL SF-36): Short form -36 questionnaire (KDQoL SF-36): Is generic measure of health that has also been used widely in trials in hemodialysis patients for the objective measure quality of life Short form -36 questionnaire (KDQoL SF-36):will be measured at baseline, and it will be measured again after eight weeks
Secondary The incremental shuttle walking test (ISWT): The incremental shuttle walking test (ISWT):Is an important marker of aerobic capacity in patients on renal dialysis The incremental shuttle walking test (ISWT):will be measured at baseline, and it will be measured again after eight weeks
Secondary Patient health questionnaire PHQ-9: Patient health questionnaire PHQ-9: Is a nine-item questionnaire designed to screen depression in primary care and other medical settings Patient health questionnaire PHQ-9:will be measured at baseline, and it will be measured again after eight weeks
See also
  Status Clinical Trial Phase
Completed NCT05980845 - The Effect Nature Sounds and Music on Hemodialysis Patients N/A
Recruiting NCT05020717 - Retrospective Survey of Hyperkalemia in Hemodialysis
Recruiting NCT04046042 - Virtual Reality Intradialysis: Last vs. First Part of the Session N/A
Recruiting NCT04094038 - The Effect of Intradialytic Parenteral Nutrition on Nutritional Status and Quality of Life in Hemodialysis Patients Phase 4
Completed NCT03311581 - The Feasibility of Propofol TCI in Hemodialysis Patients Undergoing Arteriovenous Shunt Surgery Phase 1
Completed NCT05531175 - REIKI APPLICATION PAIN, FATIGUE AND ITCHING IN HEMODIALYSIS PATIENTS N/A
Completed NCT04057313 - Coffee in Hemodialysis and Headache N/A
Completed NCT03061552 - Inferior Vena Cava Sonography in Hemodialysis Patients and Quality of Life N/A
Completed NCT03251573 - The Cohort Study of Cognitive Impairment in Chinese Hemodialysis Patients
Completed NCT05568342 - The Effect of Roy Adaptation-Based Nursing Intervention N/A
Completed NCT03527680 - Effect of Lactobacillus Rhamnosus on Serum Uremic Toxins in Hemodialysis N/A
Completed NCT04063423 - Non- Clinical Coagulation Activation During Hemodialysis
Active, not recruiting NCT06203795 - Dialysis Performance of the FX CorAL Membrane N/A
Completed NCT04319328 - Is Cefazolin, Ceftazidime and Ciprofloxacin Dosing Optimal in Hemodialysis Patients?
Completed NCT03627884 - Outcomes of the Use of Sodium Bicarbonate (8.4%) Solution as a Catheter Lock Solution to Prevent Hemodialysis Catheter Loss Due to Lumen Clot Formation Phase 4
Completed NCT05132036 - Lung Ultrasound Assessment of Fluid Overload in Haemodialysis Patients N/A
Completed NCT03076528 - An Innovative Virtually Supervised Exercise for Dialysis Patients Phase 2
Completed NCT04645121 - Carbon Monoxide-based Rebreathing Method and Bioimpedance in Hemodialysis Patients
Recruiting NCT04127877 - Bio Impedance-assisted Monitoring of Chronic Hemodialysis Patients N/A
Recruiting NCT04563091 - Potassium Kinetic During and After Hemodialysis and Potassium Profiling to Prevent Arrhythmias N/A